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Abstract
Introduction
Despite the evidence for preventing childhood morbidity and mortality, financial resources
are cited as a constraint for Governments to scale up the key health interventions in some
countries. We evaluate the cost effectiveness of implementing IMNCI program in India from
a health system and societal perspective.
Methods
We parameterized a decision analytic model to assess incremental cost effectiveness of
IMNCI program as against routine child health services for infant population at district level
in India. Using a 15-years time horizon from 2007 to 2022, we populated the model using
data on costs and effects as found from a cluster-randomized trial to assess effectiveness
of IMNCI program in Haryana state. Effectiveness was estimated as reduction in infant ill-
ness episodes, deaths and disability adjusted life years (DALY). Incremental cost per DALY
averted was used to estimate cost effectiveness of IMNCI. Future costs and effects were
discounted at a rate of 3%. Probabilistic sensitivity analysis was undertaken to estimate the
probability of IMNCI to be cost effective at varying willingness to pay thresholds.
Results
Implementation of IMNCI results in a cumulative reduction of 57384 illness episodes, 2369
deaths and 76158 DALYs among infants at district level from 2007 to 2022. Overall, from a
health system perspective, IMNCI program incurs an incremental cost of USD 34.5 (INR
1554) per DALY averted, USD 34.5 (INR 1554) per life year gained, USD 1110 (INR 49963)
per infant death averted. There is 90% probability for ICER to be cost effective at INR 2300
willingness to pay, which is 5.5% of India’s GDP per capita. From a societal perspective,
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IMNCI program incurs an additional cost of USD 24.1 (INR 1082) per DALY averted, USD
773 (INR 34799) per infant death averted and USD 26.3 (INR 1183) per illness averted in
during infancy.
Conclusion
IMNCI program in Indian context is very cost effective and should be scaled-up as a major
child survival strategy.
Introduction
Neonatal and infant mortality accounts for 55% and 77% of total under-5 child mortality in
India respectively [1–4]. Reducing high levels of infant and neonatal mortality is the key
towards achieving the fourth Millennium Development Goal (MDG-4) goal. While various
measures are being undertaken by Government of India for reducing child mortality, specific
focus remains on improving neonatal and infant survival. Against this backdrop, Integrated
Management of Childhood Illnesses (IMCI) was implemented in India after being adapted as
Integrated Management of Neonatal and Childhood Illnesses (IMNCI) [5]. Specific focus is
laid on early newborn care through home visits and improving home-based newborn care
practices, besides upgrading skills of health workers and doctors for managing sick children at
health facilities. It also aims at strengthening of health systems through better availability of
drugs and personnel, and provision of referral services [6].
Review of evidence on the impact of Integrated Management of Childhood Illnesses (IMCI)
shows that it is associated with reduction in childhood morbidity [7]. Trials from Tanzania and
Brazil indicate lesser morbidities among the children who lived in areas where the IMCI pro-
gram was implemented [8–10]. Similarly, studies from Uganda and Bangladesh show better
performance of health workers trained in IMCI in diagnosing and managing sick children
[9,11]. Studies on effect of IMNCI on childhood mortality have been less conclusive. While a
13% reduction in childhood mortality was found in Tanzania, no significant difference in mor-
tality was observed in Brazil or Bangladesh. A recent cluster-randomized trial from district
Faridabad in Haryana state of India reported a 15% (6% to 23%) reduction in infant mortality
(adjusted hazard ratio of 0.85) as a result of IMNCI program [12]. Similarly, reduction in prev-
alence of pneumonia and diarrhoea was modelled using estimates from the IMNCI effective-
ness trial [13]. The adjusted risk ratios reported for pneumonia and diarrhoea among infants
with IMNCI were 0.73 (0.52, 1.04) and 0.71 (0.60, 0.83), as compared to a setting of routine
care without IMNCI.
Despite evidence base on impact of IMCI, Child Survival Countdown conference in 2005
noted lack of financial resources as a constraint by Governments in scaling up the key health
interventions in some countries [7]. India introduced the IMNCI program in 2002 on a pilot
basis in 6 districts. Currently IMNCI is being implemented in 433 districts out of a total of 640
districts [14].
Although IMCI program has been evaluated from an economic viewpoint in Africa [8] and
Bangladesh, however, no economic evaluation of the IMNCI program has been reported in
India. Operational differences in the way IMNCI is implemented vis a vis IMCI make it diffi-
cult to generalize results from such economic evaluations from Africa to India. Secondly,
results from previous economic evaluations of IMCI program have been limited to cost com-
parisons, while an overall incremental cost effectiveness analysis is lacking [15,16]. In the
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present paper we analyze the incremental cost effectiveness of implementing IMNCI at district
level against a comparator of routine child health services. We report outcomes from both
health system and societal perspective.
Methods
Ethical Approvals
The ethics review committees of the Society for Applied Studies IRB00001359) and the World
Health Organization, Geneva (05015NCH) approved the study. Permissions were obtained
from state and district authorities, community leaders, and women under surveillance. Women
with a live birth gave informed consent before the first interview. A Study Advisory Group and
a Data Safety Monitoring Board provided oversight to the study.
Background of IMNCI Intervention Trial in India
One of the northern states, Haryana falls in the top quartile in terms of per capita gross domes-
tic product (GDP) in India. Overall population of the state is almost 25 million [17]. The
Human Development Index (HDI) value of the state is 0.545 [18]. Considering the human and
economic development in the state, it is surprising that for infant mortality rate (42 per 1000)
Haryana ranks 27 among 35 states and Union Territories in India.
In 2002, IMNCI was first implemented in 6 districts of India on pilot basis. Its implementa-
tion was scaled-up over the years to cover 433 districts in 2012. Considering the need for build-
ing evidence on effectiveness of IMNCI for reducing neonatal and infant mortality in India, a
cluster randomized trial was planned in district Faridabad of Haryana state. The catchment
area of 18 primary health centres (PHCs) was used as clusters for randomization. Prior to the
trial, a baseline study was done in 2006 to assess basic characteristics and level of neonatal mor-
tality in the 18 PHCs of Faridabad district. These 18 PHCs were stratified into 3 parts based on
the baseline neonatal mortality. Three PHCs were randomly selected from each of these 3 strata
for implementation of IMNCI program, while the remaining PHCs continued to implement
routine child health services. More details on study design are available elsewhere [12]. Despite
being contiguous, the way health institutions are organized and job responsibilities defined for
health workers, there is little possibility for risk of contamination.
A cluster randomized trial to assess the impact of IMNCI was conducted from January 2007
to April 2010 in district Faridabad of Haryana state in India [12]. Impact was assessed in terms
of reduction in infant mortality, infant morbidity (i.e. pneumonia and diarrhoea) and neonatal
severe illness (Table 1). IMNCI program was implemented in 9 primary health centres (PHCs),
with a total population of 537915. Remaining 9 PHCs, which catered to 587,213 population of
Faridabad district, implemented routine child health services without IMNCI. A pregnancy
surveillance was done in which 77587 pregnant women were identified and registered in the
population under 18 PHCs (intervention and control arm) of district Faridabad. Outcome of
the pregnancy was captured during the period from 2008–2010 through multiple contacts. A
newborn cohort was identified based on the baseline pregnancy surveillance. This newborn
cohort was followed up at 2 time points i.e. 6 months and 1 year from 2008 to 2010. Mothers
remained the respondent in these surveys conducted at different time points. The intervention
included training the frontline workers (auxiliary nurse midwife (ANM), child care workers or
anganwadi workers (AWW) and accredited social health activists (ASHA)) on clinical algo-
rithms for management of sick children. This enhanced their skills to assess, diagnose and treat
a sick child. Besides the health workers, orientation sessions were conducted for traditional
birth attendants and registered medical practitioners. AWW also performed home visits for
newborn care. Newborn and child care practices at household level were improved through a
Cost Effectiveness of IMNCI
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behaviour change communication campaign involving women group meetings, installation of
wall paintings and banners.
Health system was strengthened in the IMNCI area through triple interventions. Availabil-
ity of essential medicines such as oral rehydration solution (ORS), zinc, co-trimoxazole, para-
cetamol and gentian violet paint was improved at the level of health workers, anganwadi
workers (AWW) and ASHA through creation of village level drug depots. Sick newborn care
unit (SNCU) was established at the district hospital with facilities for radiant warmers, neonatal
resuscitator, vital sign monitor, pulse oximeter, infantometer, phototherapy unit and oxygen to
provide level-II newborn intensive care [19,20]. Similarly, newborn stabilization units were
established at three First Referral Units (FRUs).
Secondly, supervision and monitoring of program was strengthened with contractual re-
cruitment of staff to fill vacancies. Supervisory visits focused on performance of home visits,
assessment and reinforcement of clinical and counselling skills of health workers, ‘retraining’ of
skills in which heath workers were deficient, review of facility support and promotion of commu-
nity IMNCI through the existing staff. Lastly, task-based incentives were provided for IMNCI
work. ASHAs routinely get incentives for promoting institutional births (INR 100, US$ 2.3) and
immunization (INR 100, US$ 2.3). In the intervention clusters, they received additional incen-
tives for conducting postnatal home visits (INR 75, US$ 1.7), treating sick newborns and children
(INR 35, US$ 0.8), and conducting women's group meetings (INR 35, US$ 0.8).
Routine child health services. Under the control scenario, all services under the ambit of
Reproductive and Child Health (RCH) program were delivered [21]. The major difference between
intervention and control scenario was presence of training of health workers, more intense Be-
haviour Change Communication (BCC) for appropriate home-based newborn care practices,
enhanced supervision of grassroot level CHWs and health system strengthening in IMNCI area.
General Model Description
A decision tree was parameterized on MS-Excel spreadsheet to estimate the incremental cost
effectiveness of implementing IMNCI program (Figs 1 and 2). A time horizon of 15 years
Table 1. Demographic, Epidemiological and Impact Parameters for IMNCI Cost Effectiveness Decision Model.
Parameter Base Value Lower Limit Upper Limit Source
Demographic Parameters
Total Population (Rural) 1188654 950923 1426385 RGI (2011) [47]
Birth Rate (per 1000 population) 25.7 20.56 30.84 DLHS-3 [3]
Annual Growth Rate (%) 3.17 2.54 3.80 IIPS (2006) [4]
Decline in Birth Rate (%) 1.5 1.2 1.8 IIPS (2006) [4]
Infant Mortality Rate (per 1000 live births) 41.70 33.36 50.04 Bhandari N et al (2012) [12]
Epidemiological Parameters
Severe neonatal illness/Danger signs (%) 20.6 16.48 24.72 Mazumder S et al (2014) [13]
Morbidity rate for pneumonia, Infant (%) 12.30 9.84 14.76 Mazumder S et al (2014) [13]
Morbidity rate for diarrhoea, Infant (%) 28.40 22.72 34.08 Mazumder S et al (2014) [13]
Average length of Illness 8.15 6.52 9.78 Sharma AK (1999) [48]
Impact Parameters
Reduction in Infant Mortality with IMNCI (hazard ratio) 0.85 0.77 0.94 Bhandari N et al (2012) [12]
Reduction in Pneumonia among Infants with IMNCI (adjusted risk ratio) 0.73 0.52 1.04 Mazumder S et al (2014) [13]
Reduction in Diarrhoea among Infants with IMNCI (adjusted risk ratio) 0.71 0.60 0.83 Mazumder S et al (2014) [13]
Reduction in neonatal severe illness/Danger signs (adjusted risk ratio) 0.82 0.67 0.99 Mazumder S et al (2014) [13]
doi:10.1371/journal.pone.0145043.t001
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starting from base year of 2007 was considered appropriate to cover all costs and effects com-
prehensively. Ideally, period of time horizon should be such that it covers all important costs
and consequences as a result of the intervention. In the case of IMNCI, while several costs of
capital nature are incurred during the early years of implementation, however, the conse-
quences of those investments continue to occur till many years later. For example, the improve-
ments in care seeking for childhood illnesses continue to be exercised by households even after
once the costs on behaviour change communication are incurred. Similarly, benefits such as
reduction in morbidity as a result of increased coverage of preventive interventions such as
immunization and better home care practices continue to occur for several years till the chil-
dren are susceptible to the vaccine preventable diseases, or other communicable diseases. Most
of these illnesses have a predominant risk within the first 5 years of life, with gradually declin-
ing risk till about 15 years. As a result previous cost-effectiveness studies evaluating child health
interventions in India chose to use a time horizon varying from 5 years to lifetime study hori-
zon [22]. The reference case analysis recommended by WHO suggests using a lifetime study
horizon [23]. In view of these arguments we consider 15 year time horizon appropriate. We
analyzed costs and effects from both health system and societal perspective. Effect was mea-
sured in terms of illness episodes averted, child deaths prevented, life years gained and disabil-
ity-adjusted life years (DALY) averted. Both costs and effects were discounted at 3% to account
for time preference of cost and utility. We estimated the standardized unit cost from health sys-
tem and societal perspective. We report our findings as incremental cost of implementing
IMNCI for infants per DALY averted, per illness episode prevented and per infant death
averted as compared to routine care services [24].
Cost Data Collection and Analysis
Health system costs of providing services through district hospital, community health centre
(CHC), ANM, AWW and ASHA was ascertained using a bottom-up ingredients approach
[25]. This approach begins by defining the type and quantity of input or ingredients used to
produce the service output. The input may include capital and recurrent resources. The price
of each type of input (or ingredient) used is ascertained. Next, the number of each input unit
used is multiplied by the prices to obtain the overall cost of the input used. Finally, costs of all
input are summed and divided by the number of products produced to obtain the unit cost for
each product or “output” of that service. We randomly selected 8, 9 and 8 auxiliary nurse mid-
wives (ANMs), anganwadi workers (AWWs) and accredited social health activists (ASHAs)
respectively from areas implementing IMNCI program in district Faridabad in North India;
and 10, 9 and 10 ANMs, AWWs and ASHAs respectively, from areas in the same district not
implementing IMNCI. Health system costs of delivering child health care services to under-5
years children by the primary care workers, was assessed in both the alternative scenarios of
with and without IMNCI. One FRU and the district hospital were also included for costing.
Detailed methods on data sources, methods of apportionment for child health, and analyses
undertaken are available elsewhere [26] and in supplementary appendix (Appendix A in S1
Material). Cost of delivering child health services at PHC was obtained from estimates reported
in the WHO-CHOICE study [27].
Treatment seeking behaviour and out-of-pocket (OOP) costs given in Tables 2 and 3 were
estimated by analyzing data from the Indian IMNCI trial [12]. Out-of pocket costs include
money spent on medicines, diagnostics, consultation charges paid to doctor, bed-charges paid
for admission, procedures, transportation to health facility, and loss of productivity on account
of the parents’ absence from work. Productivity loss was derived based on the monthly salary
and the number of days spent away from work for child care. Mothers of 6204, 3072 and 2042
Cost Effectiveness of IMNCI
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children at the age of 29 days, 6 months and 12 months respectively were interviewed from the
intervention area. Similarly a total of 6163, 3047 and 2014 mothers with children at the age of
29 days, 6 months and 12 months respectively were interviewed from the control area. These
mothers were interviewed for any episode of diarrhoea or pneumonia during last 15 days (at 6
and 12 months) and any illness and its symptoms (at 29 days), the type of provider where treat-
ment was sought and OOP costs at each provider level (Table 2). Number and type of multiple
providers sought for a specific illness was also analyzed.
We segregated health system costs in the intervention area as those for healthcare service
delivery, program implementation and general health administration. Control area health sys-
tem costs were divided into healthcare service delivery and general health administration. Ser-
vice delivery costs comprised of costs incurred at the level of health facilities to deliver the
preventive and curative services. General health administration for child health includes costs
of monitoring and evaluation, supervision, information education and communication (IEC),
trainings entirely or partially for child health other than IMNCI. Resources in various forms
are consumed at all levels including building, space, equipment, furniture, human resources,
medicines, other consumables, and overheads such as water, electricity, laundry etc.We also
Fig 1. Decision Model for Cost-effectiveness of IMNCI in Haryana, India. Note: DH = District Hospital, CHC = Community health centre, FRU = First
referral unit, PHC = Primary health centre, SC = sub-centre, ASHA = Accredited social health activist, AWW = Anganwadi worker. Cycle repeated for 15 birth
cohorts (2008–2022).
doi:10.1371/journal.pone.0145043.g001
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estimated the cost for delivering IMNCI program in terms of costs of IMNCI trainings, capital
infrastructure, human resources, social mobilization, IEC etc. incurred specifically for program
implementation (S1 Material, S1 Dataset). We assumed the life of a training to be 7 years and
therefore dealt with the training cost as capital in nature at time of analysis. The life of training
was considered to be 7 years, based on a need for retraining health workers after an interval of
7 years. This was based on consultation with the program implementers.
The health system and OOP costs at each level of service provision, along with the morbid-
ity rate and probability of seeking treatment at a given provider were used to estimate the stan-
dardized total cost of curative care for infant population at district level using demographic
rates and health system characteristics of district Faridabad as standard district (Tables 1–3).
Preventive services, costs of monitoring and support from district level including cost of health
system strengthening and training costs were also added to arrive at total cost of infant health
care services (Table 3). The standardized cost of infant care services (overall and unit costs)
were estimated at district level for both the comparator scenarios i.e. routine services plus
Fig 2. OutcomeModel for Cost-effectiveness of IMNCI in Haryana, India. Note: In continuation to the model 1, outcomemodel describes the probable
scenarios after a neonatal or post-neonatal infant had been treated or not (irrespective of type of health facility). YLD = Years of life lived with disability,
YLL = Years of life lost due to premature mortality, DALY = Disability adjusted life years.
doi:10.1371/journal.pone.0145043.g002
Cost Effectiveness of IMNCI
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IMNCI and routine care. Detailed methods for costing are available in supplementary material
(Appendix A in S1 Material).
Data Sources and Analysis for Estimation of Effects
Intervention Setting: IMNCI. For intervention setting, findings from the Indian IMNCI
effectiveness trial on infant and neonatal mortality and morbidity were used to estimate the
impact of IMNCI [6]. We interpolated the impact of IMNCI i.e. reduction in mortality and
morbidity in intervention area from 2007 to 2010 using logarithmic distribution. For future
years, we assumed no further reduction in mortality and morbidity beyond the trial period i.e.
from 2010–2022 but we assumed sustained levels of mortality and morbidity achieved as an
effect of IMNCI. Valuation of consequences of implementation of IMNCI was done for its
effect on infant morbidity and mortality. Impact of IMNCI on morbidity in the trial was seen
only on the most common illnesses i.e. Diarrhoea and Pneumonia for infants; and severe ill-
ness/danger signs in neonatal age group. Thus, we also assumed no impact of IMNCI in reduc-
ing morbidities other than diarrhoea, pneumonia in infants and severe illness/danger signs in
neonates for our effectiveness model. This was considered appropriate as there is no local evi-
dence on impact of IMNCI on reduction of other illnesses. For impact of IMNCI on infant
mortality, the trial recorded all deaths which occurred during the infant age group. As a result,
this included effect of IMNCI on neonatal and infant mortality irrespective of cause. Finally,
our assumptions are on a more modest note in terms of current and future effects. We assumed
reduction in infant mortality of 15% (6% to 23%) with IMNCI using the estimates of India
IMNCI effectiveness trial [12]. For morbidity, we imputed reduction in diarrhoea ((adjusted
risk ratio 0.71 (0.60,0.83) and pneumonia (adjusted risk ratio 0.73 (0.52, 1.04) as reported in
the trial [13]. (Table C in S1 Material). For reduction in morbidity among infancy, the IMNCI
trial measured outcomes by following up infants at 29 days, 6 months and 1 year age and
enquired about any illness in the last 2 weeks. Consequently, impact of IMNCI on reduction of
illnesses at an age of 29 days was assumed as the corresponding reduction during neonatal
period in our model. For post-neonatal infancy period, observations on reduction on
Table 2. Treatment Seeking Behaviour Parameters for IMNCI Cost Effectiveness Decision Model.
Utilization Parameters Intervention Control
OPD Treatment Base Value Lower Limit Upper Limit Base Value Lower Limit Upper Limit
District Hospital 0.011 0.008 0.015 0.026 0.021 0.031
Primary Health Centre 0.005 0.003 0.007 0.012 0.008 0.015
AWW 0.132 0.121 0.143 0.002 0.001 0.004
ASHA 0.046 0.039 0.053 0 0 0
Chemist 0.045 0.039 0.052 0.074 0.066 0.081
Private Practitioner 0.559 0.543 0.574 0.712 0.699 0.726
Nursing Home 0.089 0.08 0.098 0.065 0.058 0.073
Private Hospital 0.022 0.018 0.027 0.052 0.045 0.058
ANM 0.001 0.004 0.009 0.001 0.004 0.009
IPD Treatment (Hospitalizations)
District Hospital 0.07 0.05 0.08 0.06 0.05 0.07
Private Hospital 0.93 0.75 1.12 0.94 0.75 1.13
Source: Estimates for treatment seeking behaviour given in the table are based on the author analysis of primary data collected under India IMNCI Impact
RCT study [6].
doi:10.1371/journal.pone.0145043.t002
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pneumonia and diarrhoea were available at 6 months and 12 months age. We populated our
model using the effectiveness estimates from trial to project reduction in diarrhoea and pneumo-
nia among post-neonatal infants, using reductions reported at 6 months follow-up during the
IMNCI trial. Two factors favoured the choice of use of 6-month observation from trial. Firstly,
the 6-month observation falls in the centre of the infancy period; and secondly, the reductions in
diarrhoea (29%) and pneumonia (27%) episodes at 6 months were more modest than corre-
sponding reductions at 1 year follow-up (37% for diarrhoea and 40% for pneumonia).
Routine infant health care services. Baseline estimates from IMNCI effectiveness trial
were used for infant mortality and morbidity in the control setting of our model [12,13]. For
control area with routine health care services, estimates of infant mortality rate from three
Table 3. Health system and out-of-pocket (OOP) Cost Parameters for IMNCI Cost Effectiveness Decision Model.
Cost of Health Care* Intervention Control
Per Infant costs Base Value Lower Limit Upper Limit Base Value Lower Limit Upper Limit
General health system administration 22 17 26 22 17 26
Program cost 57 46 68 - - -
Per Infant OPD cost
District Hospital 578 462 694 578 462 694
First Referral Unit 274 219 329 274 219 329
Community Health Centre (CHC) 274 219 329 274 219 329
Primary Health Centre (PHC) 178 143 214 178 143 214
AWW 602 482 723 573 459 688
ASHA 110 88 132 78 62 93
Subcentre 435 348 522 339 271 407
Per Infant IPD cost
District Hospital 3854 3083 4625 3854 3083 4625
First Referral Unit (Intervention) 1828 1463 2194 1828 1463 2194
Community Health Centre (CHC) 1828 1463 2194 1828 1463 2194
Primary Health Centre (PHC) 1189 951.2 1426.8 1189 951 1427
Per Infant OOP cost for OPD
District Hospital 119 61 178 89 63 115
PHC 9 0.0 18.07 34.7 4.2 65.2
AWW 0.08 0.01 0.15 0.6 0.0 1.8
ASHA 0.42 0.0 1.16 0.0 0.0 0.0
Chemist 30 26 33 34 31 38
Private Practitioner 104 97 110 111 105 117
Nursing Home 310 257 363 249 206 293
Private Hospital 351 275 427 323 279 368
Subcentre 3.7 0.4 6.9 16.3 8.1 24.5
Per Infant OOP cost for IPD
District Hospital 1900 1265 2535 1394 811 1977
Private Hospital 5365 4887 5843 5141 4328 5954
Source 1: Out-of-pocket (OOP) cost estimates (OPD and IPD) given in the table are based on the author analysis of primary data collected under India
IMNCI Impact RCT study [6].
Source 2: Health system cost estimates per infant (OPD and IPD) at different levels of facilities is based on author analysis of primary cost data collected
from district Faridabad under this study.
* The unit for costs given in the table is INR (i.e. Indian National Rupee). All costs were converted to 2009 prices.
doi:10.1371/journal.pone.0145043.t003
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different rounds of National Family Health Survey (NFHS) i.e. first in 1992–93, second in
1998–99 and third in 2005–06 were interpolated using logarithmic estimations from the year
1992 to 2006. Same estimated rate of reduction for IMR was used and extrapolated from 2007
to 2022. In order to compute the number of illness episodes among children, we used the pro-
portion of children for whom commencement of an illness episode was reported during last 15
days period during the NSS survey [3,4].
Valuing effects: primary and secondary endpoints. Primary endpoint for estimation of
effects in our study is reduction in disability adjusted life years (DALY). DALY is a sum of
years of life lost (YLL) as a result of premature mortality and years of life lived in disability
(YLD) [28]. For calculating YLL in case of an infant death, we estimated that the mean age of
infant death is 26 days. This estimation was based on the assumption that 60% of infant deaths
occur in neonatal period, 60% of neonatal deaths are early neonatal deaths (within first 7 days
of birth) [1,29,30]. We also assumed that mean age of early neonatal, late neonatal and post-
neonatal death is 3 days, 20 days and 6 months respectively; i.e. the mid-point of class interval.
We calculated YLDs separately for each of the three most common illnesses in infancy (Tables
A-B in S1 Material). Subsequently, YLDs were estimated for complications as a result of the
childhood morbidities (Table C in S1 Material). We used disability weights reported in the
Global Burden of Disease (GBD) estimates [31].
Sensitivity Analysis
We undertook univariate sensitivity analysis to assess the influence of uncertainty in each
parameter on the overall value of ICER [24]. We tested our assumption of logarithmic distribu-
tion for smoothing in trends of mortality and morbidity, by comparing ICERs computed using
a logarithmic distribution against that without any logarithmic smoothing in trends of mortal-
ity and morbidity.
We tested our assumption of future effects used in the base estimate with a best and worst
case scenario using the 95% confidence limits (CI) of estimates reported from Indian trial [12].
In the best case scenario, lower bounds of CI for costs and higher bounds of CI for relative
decline in mortality rate, morbidity rate were assumed, whereas, in contrast, higher bounds of
CI for costs and lower bounds of CI for relative decline in mortality rate, morbidity rate were
assumed, for worst case scenario. Future effects beyond 2009 were similar as in the base case.
Finally, we undertook a probabilistic sensitivity analysis (PSA) to estimate the effect of joint
uncertainty in all parameters. Probability of IMNCI program to remain cost effective at a will-
ingness to pay threshold equal to per capita gross domestic product (GDP) was estimated,
using a health system perspective. For undertaking PSA analysis, we used log-normal distribu-
tion for cost parameters and parameters for reduction in morbidity and mortality; and beta dis-
tribution for parameters related to care seeking behaviour. For rest of the parameters we used
uniform distribution to simulate random values, after assuming an upper and lower bound
which were 20% on either side of base estimate. For parameters with no ranges available from
any source, we assumed an upper and lower limit by varying the base value by 20% on either
side of base value. Monte Carlo method was used for simulating the results over 999 times.
Average costs, effects and cost-effectiveness ratios were computed along with 2.5th and 97.5th
percentile to estimate 95% confidence interval.
Results
Base Results
We found that implementation of IMNCI at district level in India yielded effects in terms of
averting 57861 illness episodes, 1967 deaths and 63249 million DALYs among infant
Cost Effectiveness of IMNCI
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population during a 15-year period from 2007 to 2022 (Table 4). The averted infant deaths
lead to an increase in the total life years by 0.13 million years after age weighting. Cumulatively,
IMNCI program as compared to routine services alone, results in about 0.06 (0.04–0.15) mil-
lion reduction (13% relative reduction) in DALYs among infants (Table 4).
In terms of cost, we found that the health system’s standardized cost per infant for imple-
mentation of routine child health services was INR 1022 (USD 22.7). With IMNCI, delivery of
child health services costs INR 1231 (USD 27.4) per infant to the health system. Overall, it
Table 4. Cost, Effects and Cost-Ef fectiveness of IMNCI Program in India.
Characteristics* Base case LL UL Best case Worst case
Cumulative Health System Cost (In Millions INR)
With IMNCI
Service delivery 555 387 745 353 794
General health system administration 9 6 12 6 13
Program cost 24 17 32 15 34
Overall 589 410 790 375 842
Without IMNCI
Service delivery 481 335 653 305 572
General health system administration 9 6 12 6 11
Overall 491 342 666 312 584
Incremental health system cost with IMNCI 98 69 124 63 258
Cumulative Societal Cost (In Millions INR)
With IMNCI 657 460 896 414 931
Without IMNCI 588 408 807 364 700
Incremental societal cost with IMNCI 68 52 89 50 230
Standardized Health System Cost Per infant (INR)
With IMNCI 1231 1097 2112 984 1477
Without IMNCI 1022 913 1781 816 1022
Incremental health system cost with IMNCI 209 184 331 168 455
Standardized Societal Cost Per infant (INR)
With IMNCI 1368 1230 2396 1083 1627
Without IMNCI 1226 1090 2158 954 1226
Incremental societal cost with IMNCI 142 139 238 129 402
Incremental Effects with IMNCI
Infant Illness Episodes prevented 57861 30702 58356 65937 57288
Infant Deaths averted 1967 1213 4343 4219 2449
Life Years added 130825 40599 152165 233354 163093
DALY averted 63249 40583 152169 135719 78742
Incremental cost effectiveness ratio, health system perspective
Cost per illness averted 1699 807 4210 956 4504
Cost per infant death averted 49963 13923 96274 14943 105340
Cost per DALY averted 1554 428 3018 465 3277
Incremental cost effectiveness ratio, Societal
Cost per illness averted 1183 0 3804 751 4022
Cost per infant death averted 34799 0 80996 11743 94075
Cost per DALY averted 1082 0 2460 365 2926
* INR—Indian National Rupee; LL–lower limit; UL–upper limit.
Note: All the estimates in the table represent the year 2009.
doi:10.1371/journal.pone.0145043.t004
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implies that IMNCI incurs an additional cost of USD 2.2 million (INR 98 million) to the health
system from 2007 to 2022. This incremental health system cost was on account of increased ser-
vice delivery for delivering additional services due to change in care seeking and program costs for
implementing IMNCI program. Three-fourth of the total incremental costs of IMNCI implemen-
tation at district level is explained by increased utilization of healthcare services at primary care
level i.e. ANM, AWW and ASHA (Fig 3). IMNCI program implementation costs account for the
one-fourth of incremental costs. This is incurred on account of trainings of healthcare personnel,
augmentation of drug and supplies and strengthening of monitoring and supervision system. Half
of the incremental costs of IMNCI implementation is on accounts of personnel costs (Fig 4).
From a societal viewpoint, the incremental cost of IMNCI was USD 1.5 million (INR 68 mil-
lion). The societal incremental costs were less than the health system’s costs on account of sav-
ings in OOP spending as a result of reduction in illness episodes.
Overall, from a health system perspective, IMNCI program incurs an incremental cost of
USD 34.5 (INR 1554) per DALY averted, USD 34.5 (INR 1554) per life year gained, USD 1110
(INR 49963) per infant death averted and USD 38 (INR 1699) per illness averted during
infancy. Similarly, using a societal perspective, IMNCI program incurs an additional cost of
USD 24.1 (INR 1082) per DALY averted, USD 773 (INR 34799) per infant death averted and
USD 26.3 (INR 1183) per illness averted in during infancy (Table 4).
Sensitivity Analysis
We found that effectiveness of IMNCI in terms of reduction in infant morbidity and mortality;
health system costs at anganwadi level and at subcentre level, baseline incidence of infant mor-
bidity and total population had highest influence on the incremental cost per DALY averted.
Fig 3. Change in costs at different levels on account of IMNCI program.
doi:10.1371/journal.pone.0145043.g003
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As a part of sensitivity analysis, we did a best and worst case scenario analysis varying the
parameter values to both extremes. In the best case scenario, where high infant mortality and mor-
bidity rates and; low implementation cost was assumed, we found an incremental cost of USD 10.3
(INR 465) and USD 8.1 (INR 365) per DALY averted from a health system and societal perspective
respectively. In the worst case scenario, where we assumed low infant mortality and morbidity
rates and; high implementation costs, we found an incremental cost of USD 72.8 (INR 3277) and
USD 65 (INR 2926) per DALY averted from a health system and societal perspective respectively
(Table 4). In both these contrasting scenarios, IMNCI remains very cost effective in India. Finally,
we found that the IMNCI program has a more than 90% probability of being cost effective from a
health system perspective at willingness to pay threshold equaling INR 2300 (USD 51) per DALY
averted, which is 5.5% of India’s GDP per capita. (Fig 5, Fig A in S1Material).
Discussion
We undertook the present economic evaluation to compare the costs and consequences of
implementing IMNCI for infant population, compared to routine child health services. In our
analysis, we report findings from both a health system and societal perspective. The approach
suggested by the commission for Macroeconomics on Health (2001) is that interventions with
an incremental cost per DALY averted less than the per capita GDP in low middle income
countries (LMICs) are “very cost effective”, and those costing less than triple the per capita
Fig 4. Distribution of incremental program implementation andmonitoring costs as a result of IMNCI.
doi:10.1371/journal.pone.0145043.g004
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GDP are “cost-effective”. India had a GDP per capita of INR 67635 (USD 1503) in 2012 [32].
Our analysis shows that IMNCI implementation costs the Government of India an additional
USD 34.5 (INR 1554) per DALY averted. There is 90% probability for IMNCI program to be a
cost effective strategy from a health system perspective at a willingness to pay threshold of
USD 51 (INR 2300). An intervention is considered as “very cost-effective” if the incremental
cost-effectiveness ratio is less than the per capita gross-domestic product; “cost-effective” if it is
between 1–3 times per capita national GDP; and “not cost-effective” if the value of ICER is
more than 3 times the GDP per capita. In the case of IMNCI, the value of ICER was less than
the GDP per capita in all simulations as part of the probabilistic sensitivity analysis. We found
more than 90% probability that the value of ICER is less than INR 2300 willingness to pay,
which is 5.5% of India’s GDP per capita in 2009. Our results show that IMNCI program is sim-
ilar in terms of its economic value to some of the most cost effective child health interventions
reported for developing South East Asian countries [33].
Our study findings point to the changes in health system and out-of-pocket costs brought
about as a result of the IMNCI program. Program implementation and monitoring explains
only 25% of the overall increase in health system costs. Remaining costs were incurred on
account of the increased demand for health services in public sector. This increased demand
was a manifestation of 2 factors–firstly, better care seeking for illnesses which were earlier not
treated, and secondly, on account of a shift in care seeking which resulted in a switch from
Fig 5. Probability of IMNCI Program to be cost effective at varying willigness to pay thresholds per DALY averted.
doi:10.1371/journal.pone.0145043.g005
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private to public sector and from higher levels of care to primary care providers. The latter
finding is also significant as it resulted in a reduction of the out-of-pocket expenditures for
treatment. This explains the lower ICER from a societal perspective than the health system per-
spective, as the former accounts for reduction in out-of-pocket expenditure.
To our knowledge, this study is the first attempt from an Asian country to systematically
ascertain the cost effectiveness of IMNCI program. A number of estimates for cost effectiveness
of individual child health interventions are available such as haemophilus influenza type ‘b’
vaccine [34], insecticide treated bednets for malaria [35,36], HIV preventive interventions for
maternal to child transmission etc [37]. Barring a study from Bangladesh, no previous eco-
nomic evaluation from a South Asian country has documented the costs and effects of delivery
of a comprehensive child health program covering the entire gamut of preventive and curative
services [38]. However, even the Bangladesh study restricts its focus to the costs and outcomes
during the neonatal age group. Another previous economic analysis for IMCI from Bangladesh
has been undertaken, however, it is restricted to assessing additional resource requirements for
IMCI, mainly in terms of community health workers [15]. Other studies from Tanzania, Brazil
and Uganda have found that IMCI program is either cost saving or cost neutral [10,39,40]. Our
study also merits to being the first one which has found the effects in the standard terms of dis-
ability adjusted life years, which facilitates in making comparisons across programs and sectors
[41]. There are several studies which have evaluated the cost effectiveness of child health inter-
ventions. In terms of findings from developing country context, IMNCI program is as cost
effective as some of the well-known child health interventions such as vitamin A and zinc forti-
fication, measles immunization, case management of pneumonia and oral rehydration therapy
[33]. Partial reason for this finding could be that IMNCI as a package promotes several of these
individual interventions. Within the literature from India, IMNCI program is as cost effective
as measles and hepatitis B vaccination, and more cost effective than other vaccines against
cholera, typhoid, haemophilus influenza type ‘b’ and rotavirus [22]. We have taken care to test
most of our modeling assumptions in the sensitivity analysis. All our parameter values have
been drawn from studies conducted either in local area or India, and for a minority few we
have drawn on literature from South East Asian region [3,4,6,27,31,42].
Our study also has a number of methodological strengths. Firstly, our decision model is
completely plausible in terms of program implementation design, care-seeking and health care
delivery system. A decision tree was considered appropriate than any other modelling method,
such as Markov model, considering the acute nature of most childhood illnesses. Secondly,
almost all the values for parameters were sourced from local Indian context. Most of these
parameter values have been drawn from a randomized controlled trial which enhances the
internal validity of our estimations. Thirdly, we test various uncertainties using a comprehen-
sive approach to sensitivity analyses. Methodological assumption of logarithmic distribution
was found not to have much effect on our results. Uncertainties in model structure were ana-
lyzed using a best and a worst case scenario which again strengthens the conclusion of cost
effectiveness of IMNCI program. Finally, the PSA analysis tests the joint parameter uncertain-
ties. All these enhance the generalizability of our findings for the cost effectiveness of IMNCI
program. In each of these sensitivity analyses, the value of incremental cost effectiveness ratio
remains less than the GDP per capita, providing credence to the conclusion of our analysis
about cost effectiveness of IMNCI in Indian context.
Our estimate of cost of delivering health care services through community health workers is
very similar to that reported by another recent study which estimated the cost of delivering
health care services through CHWs in three north Indian states [43]. Similarly, our unit esti-
mates for treating infants at district hospitals is again very close to what has been found in an
analysis including hospitals from five districts in two north Indian states [20,44].
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Among the published cost-utility studies for newborn and child health reported in a system-
atic review, the evaluation from Bangladesh is closest to our study in terms of the intervention
design [41]. The Bangladesh study evaluated cost effectiveness of two neonatal care services
packages i.e. home and community based neonatal care with the routine services in Bangla-
desh. The analysis was done using a societal perspective. Effectiveness was assessed using a
cluster-randomized controlled trial design. The authors included program costs, health system
costs and household out-of-pocket costs and reported findings in terms of incremental cost per
neonatal death averted and DALY averted. Our study is similar to the Bangladesh study in
terms of the nature of intervention, methodological features, reporting indicators and the ana-
lytical approach. [38]. This study found an incremental cost of USD 103 per DALY averted for
the intervention as compared to routine district health system. Our estimate of ICER is lower
than the Bangladesh study, which could result from a number of factors. First, the effects in the
latter study were measured only among neonates, as compared to infants in our study. Sec-
ondly, there were significantly higher out-of-pocket costs in our setting which were averted as
a result of morbidity reduction. This resulted in lower value of incremental cost effectiveness
ratio.
Limitations
Our study had certain limitations in terms of its design. Firstly, our model analyzes the costs
and effects of IMNCI among infant population. In practice, the IMNCI program targets chil-
dren less than 5 years, hence it was more pragmatic to value costs and effects in the under-5
age population. However, the trial undertaken to assess the impact of IMNCI observed effects
among neonatal and infant population only. Since there were no estimates from India on the
effectiveness of IMNCI on mortality and morbidity among 1–5 year age population, so we
chose to restrict our model to infant population. We believe that the overall conclusion in
terms of cost effectiveness of IMNCI would not change much if the costs and effects were mea-
sured in under-5 year age group. However, the value of ICER could be more in the latter sce-
nario, as the extent of mortality and morbidity reductions are likely to be less among 1–5 year
age children than the neonatal and infant age group.
Secondly, the data on health system costs was estimated as unit cost per under-5 child.
Although it was ideal to estimate unit cost per infant in health system costing, however, limita-
tions in the way data is recorded at subcentre, anganwadi, ASHA, CHC and district hospital
level did not permit such apportioning. The services utilized in reports for each of these levels
were available as either under-5 child or above-5 child, or 15–45 years old etc. Among the
under-5 children, further stratification among infants and 1–5 years was not available. How-
ever, we believe that the health system costs for infants are likely to be slightly higher than the
1–5 year population, considering higher morbidity levels and higher severity of illness among
infants which requires more resource intensive treatment. In view of this and the fact the
IMNCI results in lowering of morbidity among infants, it can be safely assumed that IMNCI
program is at least as cost effective in Indian context as found in our results.
Conclusion
To conclude, our results show that IMNCI program is a cost effective strategy as compared to
routine health care program for infant population. From a health system perspective, IMNCI is
cost effective strategy for child survival in India, with a 90% probability to be cost effective at a
willingness to pay threshold of INR 2300 (USD 51). Recommending a program or strategy for
scale-up merely on grounds of efficiency may not be prudent. Issues of sustainability and feasi-
bility are of paramount concern to the policy makers. At an incremental cost of INR 209 per
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infant per year, implementation of IMNCI imposes an incremental cost of INR 23 per capita
per year. With an overall health system spending of INR 960 per capita per year [45], this
implies nearly 2.4% increase in budget which appears reasonable considering the Government
of India’s strong commitment to raise resource allocation to health for achieving universal
health care. Sparing health care workers for 8-day long IMNCI training is again cited as a
health system challenge in the context of health workforce shortage. However, an interrupted
5-day training has been shown to be equally effective and cost-effective in Indian setting [46].
Moreover, significant augmentation of community health workers under National Health Mis-
sion–India’s flagship program, will make it possible to implement the program.
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